Bodick Neil
Chief Scientific Officer at Flexion Therapeutics Inc
- Sold, on record
- $2.4M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Jan 3, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Flexion Therapeutics IncChief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Flexion Therapeutics IncPlan not statedJan 20, 2017 2017
Sold 5,000 shares at $18.35 ($92k)
Bodick Neil, Chief Medical Officer
Sold 7.6% of holdings ($1.2M position)60,937 shares left1.3x usual sizeFiling
- 2 Form 4 sale Flexion Therapeutics IncPlan not statedFeb 24, 2017 +35 days
Sold 5,000 shares at $19.15 ($96k)
Bodick Neil, Chief Medical Officer
Sold 8.2% of holdings ($1.2M position)55,937 shares left1.3x usual sizeFiling
- 3 Form 4 sale Flexion Therapeutics IncPlan not statedMar 17, 2017 +21 days
Sold 5,000 shares at $20.41 ($102k)
Bodick Neil, Chief Medical Officer
Sold 8.9% of holdings ($1.1M position)50,937 shares left1x usual sizeFiling
- 4 Form 4 sale Flexion Therapeutics IncPlan not statedApr 17, 2017 +31 days
Sold 5,000 shares at $28.23 ($141k)
Bodick Neil, Chief Medical Officer
Sold 9.8% of holdings ($1.4M position)45,937 shares left1x usual sizeFiling
- 5 Form 4 sale Flexion Therapeutics IncPlan not statedMay 15, 2017 +28 days
Sold 6,830 shares at $18.95 ($129k)
Bodick Neil, Chief Medical Officer
Sold 14.9% of holdings ($871k position)39,107 shares left1.4x usual sizeFiling
- 6 Form 4 sale Flexion Therapeutics IncUnusualJul 3, 2018 +414 days
Sold 50,000 shares at $25.07 ($1.3M)
Bodick Neil, Chief Scientific Officer
Sold 44.5% of holdings ($2.8M position)62,307 shares left10x usual sizeFiling
- 7 Form 4 sale Flexion Therapeutics IncPlan not statedJan 3, 2019 +184 days
Sold 746 shares at $12.36 ($9k)
Bodick Neil, Chief Scientific Officer
Sold 1.1% of holdings ($810k position)64,782 shares left0.1x usual sizeFiling
- 8 Form 4 sale Flexion Therapeutics IncPlan not statedJan 3, 2020 +365 days
Sold 3,851 shares
Bodick Neil, Chief Scientific Officer
Sold 3.7% of holdings100,153 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2020 | Jan 7, 2020 | Flexion Therapeutics Inc | Chief Scientific Officer | Form 4 sale | 3,851 | 3.7% | Plan not stated | SEC | |
| Jan 3, 2019 | Jan 4, 2019 | Flexion Therapeutics Inc | Chief Scientific Officer | Form 4 sale | 746 | $9k | 1.1% | Plan not stated | SEC |
| Jul 3, 2018 | Jul 3, 2018 | Flexion Therapeutics Inc | Chief Scientific Officer | Form 4 sale | 50,000 | $1.3M | 44.5% | Unusual | SEC |
| May 15, 2017 | May 17, 2017 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 6,830 | $129k | 14.9% | Plan not stated | SEC |
| Apr 17, 2017 | Apr 18, 2017 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 5,000 | $141k | 9.8% | Plan not stated | SEC |
| Mar 17, 2017 | Mar 20, 2017 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 5,000 | $102k | 8.9% | Plan not stated | SEC |
| Feb 24, 2017 | Feb 27, 2017 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 5,000 | $96k | 8.2% | Plan not stated | SEC |
| Jan 20, 2017 | Jan 23, 2017 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 5,000 | $92k | 7.6% | Plan not stated | SEC |
| Dec 21, 2016 | Dec 22, 2016 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 10,000 | $185k | 13.2% | Plan not stated | SEC |
| Mar 16, 2015 | Mar 16, 2015 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 4,000 | $101k | 5.3% | Plan not stated | SEC |
| Mar 10, 2015 | Mar 11, 2015 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 4,000 | $97k | 5.1% | Plan not stated | SEC |
| Mar 4, 2015 | Mar 5, 2015 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 4,000 | $94k | 4.8% | Plan not stated | SEC |
| Feb 26, 2015 | Feb 26, 2015 | Flexion Therapeutics Inc | Chief Medical Officer | Form 4 sale | 4,000 | $90k | 4.6% | Plan not stated | SEC |